Nasal nanovaccines

被引：63
作者：
Bernocchi, B. [1 ,2 ,3 ]
Carpentier, R. [1 ,2 ,3 ]
Betbeder, D. [1 ,2 ,3 ,4 ]
机构：
[1] INSERM, LIRIC UMR 995, F-59000 Lille, France
[2] Univ Lille, LIRIC UMR 995, F-59000 Lille, France
[3] CHRU Lille, LIRIC UMR 995, F-59000 Lille, France
[4] Univ Artois, F-62000 Arras, France
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2017年 / 530卷 / 1-2期
关键词：
Nanoparticles; Nasal vaccines; Vaccine delivery; NALT; AIRWAY EPITHELIAL-CELLS; TRIMETHYL CHITOSAN NANOPARTICLES; GROUP-A STREPTOCOCCUS; BLOOD-BRAIN-BARRIER; VACCINE DELIVERY; DENDRITIC CELLS; LYMPHOID-TISSUE; IMMUNE-RESPONSE; INTRANASAL IMMUNIZATION; INFLUENZA VACCINE;
D O I：
10.1016/j.ijpharm.2017.07.012
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Nasal administration of vaccines is convenient for the potential stimulation of mucosal and systemic immune protection. Moreover the easy accessibility of the intranasal route renders it optimal for pandemic vaccination. Nanoparticles have been identified as ideal delivery systems and adjuvants for vaccine application. Heterogeneous protocols have been used for animal studies. This complicates the understanding of the formulation influence on the immune response and the comparison of the different nanoparticles approaches developed. Moreover anatomical and immunological differences between rodents and humans provide an additional hurdle in the rational development of nasal nanovaccines. This review will give a comprehensive expertise of the state of the art in nasal nanovaccines in animals and humans focusing on the nanomaterial used. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码：128 / 138
页数：11
相关论文
共 167 条
  • [1] Agrawal S., 2017, CLIN EXP IMMUNOL
  • [2] Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery
    Ahmed, Tarek A.
    Aljaeid, Bader M.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 483 - 507
  • [3] IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS
    ALMEIDA, AJ
    ALPAR, HO
    BROWN, MRW
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) : 198 - 203
  • [4] Impact of particle elasticity on particle-based drug delivery systems
    Anselmo, Aaron C.
    Mitragotri, Samir
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2017, 108 : 51 - 67
  • [5] Therapeutic application of peptides and proteins: parenteral forever?
    Antosova, Zuzana
    Mackova, Martina
    Kral, Vladimir
    Macek, Tomas
    [J]. TRENDS IN BIOTECHNOLOGY, 2009, 27 (11) : 628 - 635
  • [6] Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers
    Aspden, TJ
    Mason, JDT
    Jones, NS
    Lowe, J
    Skaugrud, O
    Illum, L
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) : 509 - 513
  • [7] Norovirus Vaccine against Experimental Human Norwalk Virus Illness
    Atmar, Robert L.
    Bernstein, David I.
    Harro, Clayton D.
    Al-Ibrahim, Mohamed S.
    Chen, Wilbur H.
    Ferreira, Jennifer
    Estes, Mary K.
    Graham, David Y.
    Opekun, Antone R.
    Richardson, Charles
    Mendelman, Paul M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23) : 2178 - 2187
  • [8] Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice
    Bal, Suzanne M.
    Slutter, Bram
    Verheul, Rolf
    Bouwstra, Joke A.
    Jiskoot, Wim
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (04) : 475 - 481
  • [9] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [10] Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity
    Bento, D.
    Staats, H. F.
    Goncalves, T.
    Borges, O.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 93 : 149 - 164
12345678910